Johnson Matthey (LON:JMAT – Free Report) had its price objective raised by Deutsche Bank Aktiengesellschaft from GBX 2,120 to GBX 2,400 in a research note released on Friday morning, Marketbeat reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
A number of other analysts have also recently issued reports on JMAT. Jefferies Financial Group reissued a “restricted” rating on shares of Johnson Matthey in a research note on Friday. UBS Group reaffirmed a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Berenberg Bank cut their target price on shares of Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating for the company in a research note on Monday, March 23rd. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,265.
Check Out Our Latest Analysis on JMAT
Johnson Matthey Price Performance
Johnson Matthey (LON:JMAT – Get Free Report) last posted its earnings results on Thursday, May 28th. The company reported GBX 128.50 EPS for the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. The firm had revenue of GBX 1,257.30 billion during the quarter. As a group, equities analysts expect that Johnson Matthey will post 173.4112903 EPS for the current year.
Insider Buying and Selling at Johnson Matthey
In other news, insider Liam Condon bought 14 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The stock was purchased at an average cost of GBX 1,941 per share, for a total transaction of £271.74. Also, insider Alastair Judge acquired 14 shares of Johnson Matthey stock in a transaction on Wednesday, April 15th. The shares were bought at an average price of GBX 2,022 per share, with a total value of £283.08. Over the last quarter, insiders purchased 72 shares of company stock valued at $146,198. Company insiders own 0.51% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
